Montes Archimedes Acquisition Corp.
Status: Closed Deal
U=S+W/2
W=S@11.5
| IPO Proceeds, $M | $410.72M |
|---|---|
| IPO Date | Oct 7, 2020 |
| CEO | James C. Momtazee |
| Left Lead | Citigroup |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | Roivant Sciences |
| Deal Announced | May 3, 2021 |
| Deal Size, $M | $5,000.00M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Sep 28, 2021 |
| Amendment Vote | TBD |
| Closing Date | Sep 30, 2021 |
Formerly MAAC
ROIV
ROIVW
| Price | $20.29 |
|---|---|
| Last closing price | $20.56 |
| H/L, today | $19.98 / $21.17 |
| H/L, 52-week | $4.73 / $13.24 |
| Volume, today | 8,295,393 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.